News Interest Index: Health Care Debate Tops Public Interest, Coverage

News Interest Index: Health Care Debate Tops Public Interest, Coverage

The long-running debate over health care reform continued to dominate public attention and media coverage last week as the final skirmishes played out on Capitol Hill and President Obama set out to promote the newly-enacted law.

Two-thirds of Americans (66%) say they followed the health care debate more closely than any other major news story last week. Another 5% say they followed news about vandalism and threats directed at Democrats who voted for the legislation most closely, according to the latest News Interest Index survey conducted by the Pew Research Center for the People & the Press among 1,018 adults March 26-29.

Read the full report Health Care Debate Tops Public Interest, Coverage on the Pew Research Center for the People & the Press' Web site.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.